Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Applied Industrial Technologies	AIT	6. nov 2024	268.64	+13.73
Applied Materials	AMAT	6. nov 2024	187.52	+0.56
Applied Optoelectronics	AAOI	6. nov 2024	16.21	-2.00
Applied Therapeutics	APLT	6. nov 2024	9.65	+0.21
Applovin A	APP	6. nov 2024	168.55	+2.04
AppTech Payments	APCX	6. nov 2024	0.70	+5.11
Aprea Therapeutics	APRE	6. nov 2024	4.08	+5.82
AptarGroup	ATR	6. nov 2024	173.16	+1.67
Aptevo Therapeutics	APVO	6. nov 2024	0.26	-3.73
Aptiv	APTV	6. nov 2024	53.83	-2.55
Aptorum Group A	APM	6. nov 2024	1.33	-2.21
Aptose Biosciences	APTO	6. nov 2024	0.40	+4.44
APx Acquisition I A	APXI	6. nov 2024	11.86	0.00
APx Acquisition I Unit	APXIU	6. nov 2024	11.55	0.00
Apyx Medical	APYX	6. nov 2024	1.21	+3.42
Aqua Metals	AQMS	6. nov 2024	2.28	-8.06
AquaBounty Technologies	AQB	6. nov 2024	1.10	-4.35
Aquaron Acquisition	AQU	6. nov 2024	11.00	0.00
Aquaron Acquisition Units	AQUNU	6. nov 2024	11.15	0.00
Aquestive Therapeutics	AQST	6. nov 2024	5.07	+6.62
Aramark	ARMK	6. nov 2024	39.30	+2.50
ARB IOT Group	ARBB	6. nov 2024	0.81	+44.09
Arbe Robotics	ARBE	6. nov 2024	1.73	+1.76
Arbor Realty Trust	ABR	6. nov 2024	15.03	+0.60
Arbor Realty Trust D Pref	ABR-D	6. nov 2024	19.25	-0.41
Arbor Realty Trust E Pref	ABR-E	6. nov 2024	19.51	-0.20
Arbor Realty Trust F Pref	ABR-F	6. nov 2024	20.55	-1.53
Arbutus Biopharma	ABUS	6. nov 2024	3.92	-1.01
ARC Document Solutions	ARC	6. nov 2024	3.37	0.00
Arcadia Biosciences	RKDA	6. nov 2024	4.16	+10.64

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.